INCY
INCYTE CORP
Company overview
- Market capitalization
- $25.30B
- Employees
- 2,844
- Latest publication
- 2026-09-29
About INCYTE CORP
Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan. The company offers JAKAFI for the treatment of myelofibrosis (MF), polycythemia vera, and steroid-refractory acute graft-versus-host disease; ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia; MONJUVI/ MINJUVI for the treatment of diffuse large B-cell lymphoma and Follicular Lymphoma; NIKTIMVO for the treatment of chronic graft-versus-host disease. It also provides INCA033989 for the treatment of essential thrombocythemia and MF; INCA035784 for the treatment of anti-mutant calreticulin and myeloproliferative neoplasms (MPNs); INCB160058 for the treatment of MPNs; PEMAZYRE, a selective fibroblast growth factor receptor kinase inhibitor for the treatment of unresectable biliary tract cancer, metastatic cholangiocarcinoma, and myeloid/lymphoid neoplasms; ZYNYZ to treat adults with metastatic or recurrent locally advanced Merkel cell carcinoma. The company's clinical stage products include INCB123667 for ovarian cancer; INCB161734 for solid tumors; INCA33890 for cancers; Ruxolitinib cream for atopic dermatitis, hidradenitis suppurativa (HS), and prurigo nodularis; Povorcitinib for HS, nonsegmental vitiligo, prurigo nodularis, and asthma; and INCB00928 for the treatment of fibrodysplasia ossificans progressive. It has collaboration and license agreement with Novartis, Lilly, and Syndax. The company sells its products to specialty and retail pharmacies, hospital pharmacies, and distributors. The company was formerly known as Incyte Genomics Inc and changed its name to Incyte Corporation in March 2003. Incyte Corporation was incorporated in 1991 and is headquartered in Wilmington, Delaware.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,674,039,000USD | 1,272,676,000USD | 1,506,835,000USD | 1,365,980,000USD | 1,215,529,000USD | 1,052,898,000USD | 1,178,698,000USD | 1,137,871,000USD |
| Cost Of Revenue | 104,957,000USD | 104,500,000USD | 121,100,000USD | 99,000,000USD | 78,800,000USD | 73,200,000USD | 88,500,000USD | 86,000,000USD |
| Gross Profit | 1,569,082,000USD | 1,168,176,000USD | 1,385,735,000USD | 1,266,980,000USD | 1,136,729,000USD | 979,698,000USD | 1,090,198,000USD | 1,051,871,000USD |
| Research Development | 516,950,000USD | 515,903,000USD | 611,372,000USD | 506,584,000USD | 494,917,000USD | 437,279,000USD | 466,034,000USD | 573,174,000USD |
| Selling General Administrative | 351,735,000USD | 328,100,000USD | 390,400,000USD | 329,100,000USD | 331,000,000USD | 325,700,000USD | 326,800,000USD | 309,200,000USD |
| Total Operating Expenses | 871,184,000USD | 844,003,000USD | 1,001,772,000USD | 835,684,000USD | 825,917,000USD | 762,979,000USD | 792,834,000USD | 905,786,000USD |
| Operating Income | 697,898,000USD | 324,173,000USD | 383,963,000USD | 431,296,000USD | 310,812,000USD | 216,719,000USD | 297,364,000USD | 146,085,000USD |
| Total Other Income Expense Net | 53,616,000USD | 19,427,000USD | 5,978,000USD | 51,012,000USD | 247,200,000USD | 17,471,000USD | 16,360,000USD | 10,439,000USD |
| Interest Income | 38,118,000USD | 33,687,000USD | 30,754,000USD | 26,781,000USD | 25,136,000USD | 22,929,000USD | 10,002,000USD | 24,195,000USD |
| Interest Expense | 582,000USD | 569,000USD | 582,000USD | 592,000USD | 594,000USD | 660,000USD | 419,000USD | 774,000USD |
| Income Before Tax | 751,514,000USD | 343,600,000USD | 389,941,000USD | 482,308,000USD | 558,012,000USD | 234,190,000USD | 313,724,000USD | 156,524,000USD |
| Income Tax Expense | 165,909,000USD | 40,270,000USD | 90,662,000USD | 58,139,000USD | 153,013,000USD | 75,987,000USD | 112,512,000USD | 50,068,000USD |
| Net Income | 585,605,000USD | 303,330,000USD | 299,279,000USD | 424,169,000USD | 404,999,000USD | 158,203,000USD | 201,212,000USD | 106,456,000USD |
| Net Income Applicable To Common Shares | 585,605,000USD | — | — | — | — | — | — | — |
| Net Interest Income | — | 33,118,000USD | 30,172,000USD | 26,189,000USD | 24,542,000USD | 22,269,000USD | 9,583,000USD | 23,421,000USD |
| Tax Provision | — | 40,270,000USD | 90,662,000USD | 58,139,000USD | 153,013,000USD | 75,987,000USD | 112,512,000USD | 50,068,000USD |
| Net Income From Continuing Ops | — | 303,330,000USD | 299,279,000USD | 424,169,000USD | 404,999,000USD | 158,203,000USD | 201,212,000USD | 106,456,000USD |
| Ebit | — | 344,169,000USD | 390,523,000USD | 482,900,000USD | 558,606,000USD | 234,850,000USD | 314,143,000USD | 157,298,000USD |
| Ebitda | — | 367,971,000USD | 414,505,000USD | 506,923,000USD | 581,525,000USD | 257,212,000USD | 336,876,000USD | 179,818,000USD |
| Depreciation And Amortization | — | 23,802,000USD | 23,982,000USD | 24,023,000USD | 22,919,000USD | 22,362,000USD | 22,733,000USD | 22,520,000USD |
| Reconciled Depreciation | — | 23,802,000USD | 23,982,000USD | 24,023,000USD | 22,919,000USD | 22,362,000USD | 22,733,000USD | 22,520,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 16,411,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20162016-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 5,141,242,000USD | 4,241,217,000USD | 3,695,649,000USD | 3,394,635,000USD | 2,986,267,000USD | 2,158,759,000USD | 1,881,883,000USD | 1,105,719,000USD |
| Cost Of Revenue | 372,100,000USD | 312,100,000USD | 254,990,000USD | 207,000,000USD | 150,991,000USD | 114,249,000USD | 94,123,000USD | 58,187,000USD |
| Gross Profit | 4,769,142,000USD | 3,929,117,000USD | 3,440,659,000USD | 3,187,635,000USD | 2,835,276,000USD | 2,044,510,000USD | 1,787,760,000USD | 1,047,532,000USD |
| Research Development | 2,050,152,000USD | 2,606,848,000USD | 1,627,594,000USD | 1,585,936,000USD | 1,458,179,000USD | 1,154,111,000USD | 1,197,957,000USD | 581,861,000USD |
| Selling General Administrative | 1,376,200,000USD | 1,222,000,000USD | 1,161,300,000USD | 1,002,100,000USD | 739,600,000USD | 468,700,000USD | 424,334,000USD | 303,251,000USD |
| Total Operating Expenses | 3,426,352,000USD | 3,827,823,000USD | 2,785,301,000USD | 2,596,009,000USD | 2,249,499,000USD | 1,642,504,000USD | 1,658,537,000USD | 902,534,000USD |
| Operating Income | 1,342,790,000USD | 101,294,000USD | 655,358,000USD | 591,626,000USD | 585,777,000USD | 402,006,000USD | 129,223,000USD | 144,998,000USD |
| Interest Income | 105,600,000USD | 128,710,000USD | 172,348,000USD | 39,932,000USD | 10,647,000USD | 84,785,000USD | 45,636,000USD | 4,412,000USD |
| Interest Expense | 2,428,000USD | 2,280,000USD | 2,551,000USD | 2,666,000USD | 1,908,000USD | 1,855,000USD | 1,543,000USD | 38,745,000USD |
| Net Interest Income | 103,172,000USD | 126,430,000USD | 106,203,000USD | -2,666,000USD | -1,908,000USD | -1,855,000USD | -1,543,000USD | -34,333,000USD |
| Income Before Tax | 1,664,451,000USD | 316,630,000USD | 834,215,000USD | 529,116,000USD | 570,444,000USD | 486,791,000USD | 115,347,000USD | 107,404,000USD |
| Income Tax Expense | 377,801,000USD | 284,015,000USD | 236,616,000USD | 188,456,000USD | -378,137,000USD | 39,885,000USD | 5,854,000USD | 3,182,000USD |
| Tax Provision | 377,801,000USD | 284,015,000USD | 218,893,000USD | 188,456,000USD | -378,137,000USD | 39,885,000USD | 5,854,000USD | 3,182,000USD |
| Net Income | 1,286,650,000USD | 32,615,000USD | 597,599,000USD | 340,660,000USD | 948,581,000USD | 446,906,000USD | 109,493,000USD | 104,222,000USD |
| Net Income From Continuing Ops | 1,286,650,000USD | 32,615,000USD | 424,981,000USD | 340,660,000USD | 948,581,000USD | 446,906,000USD | 109,493,000USD | 104,222,000USD |
| Ebit | 1,666,879,000USD | 318,910,000USD | 836,766,000USD | 531,782,000USD | 572,352,000USD | 488,646,000USD | 116,890,000USD | 146,149,000USD |
| Ebitda | 1,760,165,000USD | 408,158,000USD | 919,426,000USD | 599,637,000USD | 630,196,000USD | 543,179,000USD | 171,859,000USD | 204,574,000USD |
| Depreciation And Amortization | 93,286,000USD | 89,248,000USD | 82,660,000USD | 67,855,000USD | 57,844,000USD | 54,533,000USD | 54,969,000USD | 58,425,000USD |
| Reconciled Depreciation | 93,286,000USD | 89,248,000USD | 79,116,000USD | 67,855,000USD | 57,844,000USD | 54,533,000USD | 54,969,000USD | — |
| Total Other Income Expense Net | 321,661,000USD | 215,336,000USD | 178,857,000USD | -62,510,000USD | -15,333,000USD | 84,785,000USD | -13,876,000USD | -37,594,000USD |
| Selling And Marketing Expenses | — | 20,157,000USD | 5,638,000USD | 40,000USD | 40,000USD | 11,000USD | 10,600,000USD | — |
| Non Operating Income Net Other | — | — | — | 39,932,000USD | 10,647,000USD | 52,182,000USD | 31,760,000USD | 1,151,000USD |
| Net Income Applicable To Common Shares | — | — | — | 340,660,000USD | 948,581,000USD | 446,906,000USD | 109,493,000USD | 104,222,000USD |
| Unclassified Operating Expenses | — | — | — | — | 51,680,000USD | 19,682,000USD | 25,646,000USD | 17,422,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 7,872,647,000USD | 7,339,113,000USD | 6,957,973,000USD | 6,330,356,000USD | 5,821,354,000USD | 5,749,365,000USD | 5,444,322,000USD | 5,012,434,000USD |
| Cash And Equivalents | 3,982,375,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 6,026,572,000USD | 5,484,260,000USD | 5,023,902,000USD | 4,277,889,000USD | 3,643,701,000USD | 3,507,421,000USD | 3,239,030,000USD | 2,808,708,000USD |
| Other Current Assets | 253,087,000USD | 301,312,000USD | 317,831,000USD | 368,732,000USD | 295,648,000USD | 211,654,000USD | 168,912,000USD | 205,128,000USD |
| Other Non Current Assets | 86,759,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 1,528,220,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 1,312,096,000USD | 1,489,649,000USD | 1,515,170,000USD | 1,338,729,000USD | 1,278,619,000USD | 1,720,290,000USD | 1,641,847,000USD | 1,501,650,000USD |
| Other Current Liabilities | 68,539,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 124,515,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 6,344,427,000USD | 5,552,244,000USD | 5,167,478,000USD | 4,651,194,000USD | 4,170,903,000USD | 3,667,563,000USD | 3,447,628,000USD | 3,171,220,000USD |
| Total Equity Including Noncontrolling Interest | 6,344,427,000USD | — | — | — | — | — | — | — |
| Inventory | 112,542,000USD | 115,624,000USD | 101,060,000USD | 83,447,000USD | 83,423,000USD | 63,975,000USD | 58,872,000USD | 70,442,000USD |
| Property Plant Equipment Net | 709,469,000USD | 746,838,000USD | 758,405,000USD | 826,789,000USD | 827,544,000USD | 795,251,000USD | 794,214,000USD | 798,174,000USD |
| Goodwill | 133,000,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 103,196,000USD | 110,164,000USD | 117,131,000USD | 119,421,000USD | 126,419,000USD | 107,611,000USD | 113,803,000USD | 119,994,000USD |
| Accounts Payable | 250,401,000USD | 228,624,000USD | 209,938,000USD | 171,925,000USD | 241,094,000USD | 195,537,000USD | 197,465,000USD | 178,710,000USD |
| Short Term Debt | 5,588,000USD | 4,413,000USD | 10,213,000USD | 10,386,000USD | 10,648,000USD | 10,476,000USD | 10,002,000USD | 8,284,000USD |
| Common Stock | 201,000USD | 200,000USD | 198,000USD | 196,000USD | 194,000USD | 193,000USD | 193,000USD | 192,000USD |
| Retained Earnings | 1,102,704,000USD | 517,099,000USD | 213,769,000USD | -85,510,000USD | -509,679,000USD | -914,678,000USD | -1,072,881,000USD | -1,274,093,000USD |
| Accumulated Other Comprehensive Income | 19,718,000USD | 22,314,000USD | 25,462,000USD | 14,555,000USD | 13,439,000USD | -6,238,000USD | -13,121,000USD | 15,655,000USD |
| Total Liab | — | 1,786,869,000USD | 1,803,373,000USD | 1,679,162,000USD | 1,650,451,000USD | 2,081,802,000USD | 1,996,694,000USD | 1,841,214,000USD |
| Other Current Liab | — | 1,256,612,000USD | 1,295,019,000USD | 1,156,418,000USD | 1,022,402,000USD | 1,514,277,000USD | 1,410,599,000USD | 1,281,506,000USD |
| Capital Stock | — | 200,000USD | 198,000USD | 196,000USD | 194,000USD | 193,000USD | 193,000USD | 192,000USD |
| Good Will | — | 133,000,000USD | 133,000,000USD | 155,593,000USD | 155,593,000USD | 155,593,000USD | 155,593,000USD | 155,593,000USD |
| Other Assets | — | 39,775,000USD | 385,840,000USD | 424,748,000USD | 343,357,000USD | — | — | — |
| Cash | — | 3,461,114,000USD | 3,097,817,000USD | 2,455,006,000USD | 1,954,969,000USD | 1,941,722,000USD | 1,687,829,000USD | 1,304,109,000USD |
| Cash And Short Term Investments | — | 4,015,825,000USD | 3,580,604,000USD | 2,929,820,000USD | 2,421,738,000USD | 2,408,658,000USD | 2,158,092,000USD | 1,774,688,000USD |
| Net Debt | — | -3,427,287,000USD | -3,028,389,000USD | -2,413,739,000USD | -1,912,561,000USD | -1,898,603,000USD | -1,644,285,000USD | -1,267,602,000USD |
| Short Long Term Debt Total | — | 33,827,000USD | 69,428,000USD | 41,267,000USD | 42,408,000USD | 43,119,000USD | 43,544,000USD | 36,507,000USD |
| Long Term Investments | — | 54,582,000USD | 47,991,000USD | 21,870,000USD | 13,313,000USD | 17,463,000USD | 18,814,000USD | 27,566,000USD |
| Short Term Investments | — | 554,711,000USD | 482,787,000USD | 474,814,000USD | 466,769,000USD | 466,936,000USD | 470,263,000USD | 470,579,000USD |
| Net Receivables | — | 1,051,499,000USD | 1,024,406,999USD | 895,890,000USD | 842,892,000USD | 823,134,000USD | 853,154,000USD | 758,450,000USD |
| Property Plant Equipment Gross | — | 1,135,834,000USD | 1,133,471,000USD | 1,187,392,000USD | 1,173,915,000USD | 1,138,882,000USD | 1,122,198,000USD | 1,113,985,000USD |
| Common Stock Shares Outstanding | — | 206,830,000shares | 204,766,000shares | 201,429,000shares | 198,744,000shares | 198,197,000shares | 197,423,000shares | 195,838,000shares |
| Non Current Assets Total | — | 1,815,078,000USD | 1,523,830,000USD | 1,629,941,000USD | 2,177,653,000USD | 2,241,944,000USD | 2,205,292,000USD | 2,203,726,000USD |
| Non Current Liabilities Total | — | 226,604,000USD | 288,203,000USD | 340,433,000USD | 371,832,000USD | 361,512,000USD | 354,847,000USD | 339,564,000USD |
| Non Current Liabilities Other | — | 197,203,000USD | 245,126,000USD | 309,552,000USD | 340,072,000USD | 328,869,000USD | 321,305,000USD | 311,341,000USD |
| Non Currrent Assets Other | — | 317,974,000USD | -47,991,000USD | -21,870,000USD | 402,504,000USD | 397,127,000USD | 360,797,000USD | 340,089,000USD |
| Net Working Capital | — | 3,994,611,000USD | 3,508,732,000USD | 2,939,160,000USD | 2,365,082,000USD | 1,787,131,000USD | 1,597,183,000USD | 1,307,058,000USD |
| Unclassified Non Current Assets | — | 412,745,000USD | 81,463,000USD | 81,520,000USD | 308,923,000USD | 768,899,000USD | 762,071,000USD | 762,310,000USD |
| Unclassified Non Current Liabilities | — | 29,401,000USD | 43,077,000USD | 30,881,000USD | 31,760,000USD | 32,643,000USD | — | — |
| Unclassified Equity | — | 5,012,431,000USD | 4,927,851,000USD | 4,721,757,000USD | 4,666,755,000USD | 4,588,093,000USD | 4,533,244,000USD | 4,429,274,000USD |
| Long Term Debt | — | — | — | — | — | — | 33,542,000USD | 28,223,000USD |
| Unclassified Current Liabilities | — | — | — | — | — | — | 23,781,000USD | -656,567,000USD |
| Current Deferred Revenue | — | — | — | — | — | — | — | 689,717,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 6,957,973,000USD | 5,444,322,000USD | 6,782,107,000USD | 5,840,984,000USD | 4,933,352,000USD | 3,560,918,000USD | 3,426,750,000USD | 2,645,762,000USD |
| Intangible Assets | 117,131,000USD | 113,803,000USD | 123,545,000USD | 129,219,000USD | 150,755,000USD | 172,291,000USD | 193,828,000USD | 215,364,000USD |
| Other Current Assets | 317,831,000USD | 168,912,000USD | 182,830,000USD | 167,011,000USD | 126,278,000USD | 60,098,000USD | 94,179,000USD | 79,366,000USD |
| Total Liab | 1,803,373,000USD | 1,996,694,000USD | 1,592,270,000USD | 1,470,865,000USD | 1,163,348,000USD | 949,650,000USD | 828,344,000USD | 719,795,000USD |
| Total Stockholder Equity | 5,167,478,000USD | 3,447,628,000USD | 5,189,837,000USD | 4,370,119,000USD | 3,770,004,000USD | 2,611,268,000USD | 2,598,406,000USD | 1,925,967,000USD |
| Other Current Liab | 1,295,019,000USD | 1,416,182,000USD | 1,079,358,000USD | 861,049,000USD | 669,009,000USD | 517,470,000USD | 76,064,000USD | 66,412,000USD |
| Common Stock | 198,000USD | 193,000USD | 224,000USD | 223,000USD | 221,000USD | 219,000USD | 216,000USD | 213,000USD |
| Capital Stock | 198,000USD | 193,000USD | 224,000USD | 223,000USD | 221,000USD | 219,000USD | 216,000USD | 213,000USD |
| Retained Earnings | 213,769,000USD | -1,072,881,000USD | 160,385,000USD | -437,214,000USD | -777,874,000USD | -1,726,455,000USD | -1,430,758,000USD | -1,877,759,000USD |
| Good Will | 133,000,000USD | 155,593,000USD | 155,593,000USD | 155,593,000USD | 155,593,000USD | 155,593,000USD | 155,593,000USD | 155,593,000USD |
| Other Assets | 385,840,000USD | — | — | 564,038,000USD | 467,538,000USD | 25,146,000USD | 55,559,000USD | 23,601,000USD |
| Cash | 3,097,817,000USD | 1,687,829,000USD | 3,213,376,000USD | 2,951,422,000USD | 2,057,440,000USD | 1,513,008,000USD | 1,832,684,000USD | 1,163,980,000USD |
| Cash And Short Term Investments | 3,580,604,000USD | 2,158,092,000USD | 3,656,043,000USD | 3,238,965,000USD | 2,348,192,000USD | 1,801,377,000USD | 2,117,554,000USD | 1,438,323,000USD |
| Total Current Assets | 5,023,902,000USD | 3,239,030,000USD | 4,645,402,000USD | 4,092,850,000USD | 3,118,674,000USD | 2,359,894,000USD | 2,537,047,000USD | 1,855,855,000USD |
| Total Current Liabilities | 1,515,170,000USD | 1,641,847,000USD | 1,240,379,000USD | 1,157,077,000USD | 854,308,000USD | 631,195,000USD | 500,462,000USD | 415,360,000USD |
| Net Debt | -3,028,389,000USD | -1,644,285,000USD | -3,175,089,000USD | -2,909,965,000USD | -2,012,619,000USD | -1,465,477,000USD | -1,781,802,000USD | -1,146,546,000USD |
| Short Term Debt | 10,213,000USD | 10,002,000USD | 9,125,000USD | 11,374,000USD | 13,189,000USD | 14,958,000USD | 28,307,000USD | 18,696,000USD |
| Short Long Term Debt Total | 69,428,000USD | 37,961,000USD | 38,287,000USD | 41,457,000USD | 44,821,000USD | 47,531,000USD | 60,225,000USD | 36,130,000USD |
| Long Term Investments | 47,991,000USD | 18,814,000USD | 187,716,000USD | 133,676,000USD | 221,266,000USD | 222,301,000USD | 133,657,000USD | 99,199,000USD |
| Short Term Investments | 482,787,000USD | 470,263,000USD | 442,667,000USD | 287,543,000USD | 290,752,000USD | 288,369,000USD | 284,870,000USD | 274,343,000USD |
| Net Receivables | 1,024,406,999USD | 853,154,000USD | 743,557,000USD | 644,879,000USD | 616,300,000USD | 481,994,000USD | 308,809,000USD | 307,598,000USD |
| Inventory | 101,060,000USD | 58,872,000USD | 62,972,000USD | 41,995,000USD | 27,904,000USD | 16,425,000USD | 16,505,000USD | 10,405,000USD |
| Accounts Payable | 209,938,000USD | 197,465,000USD | 109,601,000USD | 277,546,000USD | 172,110,000USD | 98,767,000USD | 83,647,000USD | 103,827,000USD |
| Property Plant Equipment Net | 758,405,000USD | 794,214,000USD | 777,048,000USD | 765,608,000USD | 751,468,000USD | 588,076,000USD | 406,625,000USD | 319,751,000USD |
| Property Plant Equipment Gross | 1,133,471,000USD | 1,122,198,000USD | 1,046,982,000USD | 765,608,000USD | 751,468,000USD | 559,625,000USD | 406,625,000USD | 319,751,000USD |
| Accumulated Other Comprehensive Income | 25,462,000USD | -13,121,000USD | 13,106,000USD | 15,069,000USD | -19,454,000USD | -15,360,000USD | -15,542,000USD | -10,165,000USD |
| Common Stock Shares Outstanding | 200,700,000shares | 210,530,000shares | 225,928,000shares | 223,958,000shares | 222,074,000shares | 218,073,000shares | 217,657,000shares | 215,635,000shares |
| Non Current Assets Total | 1,523,830,000USD | 2,205,292,000USD | 2,136,705,000USD | 1,748,134,000USD | 1,814,678,000USD | 1,201,024,000USD | 889,703,000USD | 789,907,000USD |
| Non Current Liabilities Total | 288,203,000USD | 354,847,000USD | 351,891,000USD | 313,788,000USD | 309,040,000USD | 318,455,000USD | 327,882,000USD | 304,435,000USD |
| Non Current Liabilities Other | 245,126,000USD | 321,305,000USD | 322,729,000USD | 313,788,000USD | 309,040,000USD | 318,455,000USD | 315,004,000USD | 277,084,000USD |
| Non Currrent Assets Other | -47,991,000USD | 360,797,000USD | 260,917,000USD | 106,097,000USD | 68,058,000USD | 60,709,000USD | 55,559,000USD | 23,601,000USD |
| Net Working Capital | 3,508,732,000USD | 1,597,183,000USD | 3,405,023,000USD | 2,935,773,000USD | 2,264,366,000USD | 1,728,699,000USD | 1,968,148,000USD | 1,406,977,000USD |
| Unclassified Non Current Assets | 81,463,000USD | 762,071,000USD | 631,886,000USD | -106,097,000USD | — | -23,092,000USD | -111,118,000USD | -47,202,000USD |
| Unclassified Non Current Liabilities | 43,077,000USD | — | — | -299,679,000USD | -275,632,000USD | -266,000,000USD | -276,654,000USD | -267,167,000USD |
| Unclassified Equity | 4,927,851,000USD | 4,533,244,000USD | 5,015,898,000USD | 4,791,818,000USD | 4,566,890,000USD | 4,352,645,000USD | 4,044,274,000USD | 3,813,465,000USD |
| Long Term Debt | — | 33,542,000USD | 29,162,000USD | 30,083,000USD | 31,632,000USD | — | 18,300,000USD | 17,434,000USD |
| Unclassified Current Liabilities | — | 18,198,000USD | -967,611,000USD | -450,833,000USD | -617,022,000USD | -448,857,000USD | -18,300,000USD | — |
| Current Deferred Revenue | — | — | 1,009,906,000USD | 457,941,000USD | 617,022,000USD | 448,857,000USD | 312,444,000USD | 226,425,000USD |
| Other Liab | — | — | — | 269,596,000USD | 244,000,000USD | 266,000,000USD | 271,232,000USD | 277,084,000USD |
| Net Tangible Assets | — | — | — | 4,085,307,000USD | 3,463,656,000USD | 2,283,384,000USD | 2,248,985,000USD | 1,555,010,000USD |
| Short Long Term Debt | — | — | — | — | — | — | 18,300,000USD | — |
| Unclassified Current Assets | — | — | — | — | — | — | — | 20,163,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 50,278,000USD |
| Stock Based Compensation | 131,389,000USD |
| Deferred Income Tax | 179,037,000USD |
| Other Non Cash Items | -14,385,000USD |
| Change To Account Receivables | -100,822,000USD |
| Change To Inventory | -24,105,000USD |
| Change To Liabilities | -243,170,000USD |
| Change In Working Capital | -83,896,000USD |
| Operating Cash Flow | 877,013,000USD |
| Net Investments | -72,383,000USD |
| Unclassified Investing Cash Flow | -67,613,000USD |
| Investing Cash Flow | -139,996,000USD |
| Net Debt Issuance | -2,342,000USD |
| Common Stock Issuance | 173,073,000USD |
| Net Common Stock Issuance | -10,888,000USD |
| Unclassified Financing Cash Flow | -9,565,000USD |
| Financing Cash Flow | 150,278,000USD |
| Effect Of Forex Changes On Cash | -2,773,000USD |
| Change In Cash | 884,522,000USD |
| End Cash Flow | 3,984,191,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 303,330,000USD | 299,279,000USD | 424,169,000USD | 404,999,000USD | 158,203,000USD | 201,212,000USD | 106,456,000USD | -444,601,000USD |
| Depreciation | 23,802,000USD | 23,982,000USD | 24,023,000USD | 22,919,000USD | 22,362,000USD | 22,733,000USD | 22,520,000USD | 22,048,000USD |
| Stock Based Compensation | 64,126,000USD | 62,157,000USD | 61,598,000USD | 64,609,000USD | 60,982,000USD | 71,718,000USD | 77,922,000USD | 56,640,000USD |
| Other Non Cash Items | -4,907,000USD | 41,183,000USD | -14,097,000USD | 18,400,000USD | 18,207,000USD | 1,908,000USD | 28,980,000USD | -38,714,000USD |
| Change To Account Receivables | -27,027,000USD | -128,497,000USD | -53,001,000USD | -20,229,000USD | 30,955,000USD | -96,693,000USD | -19,400,000USD | 6,476,000USD |
| Change To Inventory | -12,226,000USD | -4,859,000USD | -5,555,000USD | -19,525,000USD | -28,574,000USD | -34,281,000USD | -8,376,000USD | -27,779,000USD |
| Change In Working Capital | -80,416,000USD | 103,203,000USD | -60,421,000USD | -582,963,000USD | 13,019,000USD | 83,591,000USD | 108,869,000USD | -153,454,000USD |
| Total Cash From Operating Activities | 369,351,000USD | 543,301,000USD | 559,389,000USD | 44,741,000USD | 266,067,000USD | 381,218,000USD | 310,871,000USD | -575,563,000USD |
| Capital Expenditures | -10,200,000USD | -21,877,000USD | -14,747,000USD | -19,074,000USD | -3,169,000USD | -17,384,000USD | -17,687,000USD | -55,543,000USD |
| Free Cash Flow | 359,151,000USD | 521,424,000USD | 544,642,000USD | 25,667,000USD | 262,898,000USD | 363,834,000USD | 293,184,000USD | -631,106,000USD |
| Investments | -73,003,000USD | -15,542,000USD | -47,416,000USD | -18,872,000USD | 1,097,000USD | -21,465,000USD | 38,274,000USD | 213,820,000USD |
| Total Cashflows From Investing Activities | -88,203,000USD | -37,419,000USD | -47,416,000USD | -18,872,000USD | 1,097,000USD | -21,465,000USD | 38,274,000USD | 213,820,000USD |
| Net Borrowings | -1,184,000USD | -1,158,000USD | -1,141,000USD | -1,155,000USD | -1,090,000USD | -1,037,000USD | -979,000USD | — |
| Total Cash From Financing Activities | 84,822,000USD | 137,739,000USD | -12,778,000USD | -11,246,000USD | -12,676,000USD | 20,394,000USD | -32,351,000USD | -1,997,177,000USD |
| Sale Purchase Of Stock | -6,885,000USD | 0USD | 0USD | -19,100,000USD | 19,185,000USD | 0USD | -103,000USD | -2,004,687,000USD |
| Change In Cash | 363,281,000USD | 642,811,000USD | 500,036,000USD | 13,426,000USD | 253,936,000USD | 383,605,000USD | 316,922,000USD | -2,358,911,000USD |
| Begin Period Cash Flow | 3,099,669,000USD | 2,455,006,000USD | 1,956,813,000USD | 1,943,387,000USD | 1,689,451,000USD | 1,305,846,000USD | 987,293,000USD | 3,346,204,000USD |
| End Period Cash Flow | 3,462,950,000USD | 3,097,817,000USD | 2,456,849,000USD | 1,956,813,000USD | 1,943,387,000USD | 1,689,451,000USD | 1,305,846,000USD | 987,293,000USD |
| Other Cashflows From Investing Activities | -5,000,000USD | — | -25,000,000USD | — | — | — | -17,687,000USD | 267,963,000USD |
| Other Cashflows From Financing Activities | -5,034,000USD | -21,312,000USD | -55,067,000USD | -5,875,000USD | -14,825,000USD | -1,983,359,000USD | -32,551,000USD | -6,062,000USD |
| Unclassified Operating Cash Flow | 63,416,000USD | 13,497,000USD | 124,117,000USD | 116,777,000USD | -6,706,000USD | — | -33,876,000USD | -17,482,000USD |
| Unclassified Financing Cash Flow | 97,925,000USD | 160,209,000USD | 43,430,000USD | 14,884,000USD | -15,946,000USD | 2,004,790,000USD | 1,282,000USD | — |
| Unclassified Investing Cash Flow | — | — | 39,747,000USD | 19,074,000USD | 3,169,000USD | 17,384,000USD | 35,374,000USD | -212,420,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 1,286,650,000USD | 32,615,000USD | 597,599,000USD | 340,660,000USD | 948,581,000USD | -295,697,000USD | 446,906,000USD | 109,493,000USD |
| Depreciation | 93,286,000USD | 89,248,000USD | 82,660,000USD | 67,855,000USD | 57,844,000USD | 51,807,000USD | 54,533,000USD | 54,969,000USD |
| Stock Based Compensation | 249,346,000USD | 266,058,000USD | 215,889,000USD | 188,420,000USD | 183,006,000USD | 177,877,000USD | 166,589,000USD | 148,153,000USD |
| Other Non Cash Items | 63,693,000USD | -105,275,000USD | 7,888,000USD | 117,105,000USD | 40,230,000USD | 13,505,000USD | -14,290,000USD | 70,610,000USD |
| Change To Account Receivables | -170,772,000USD | -111,586,000USD | -98,678,000USD | -28,579,000USD | -134,306,000USD | -173,185,000USD | -1,211,000USD | -41,299,000USD |
| Change To Inventory | -58,513,000USD | -127,633,000USD | -170,151,000USD | -67,504,000USD | -20,965,000USD | -19,468,000USD | -6,100,000USD | 4,043,000USD |
| Change In Working Capital | -527,162,000USD | 138,244,000USD | -248,651,000USD | 198,810,000USD | -14,569,000USD | -71,741,000USD | 57,295,000USD | -46,539,000USD |
| Total Cash From Operating Activities | 1,413,498,000USD | 335,337,000USD | 496,487,000USD | 969,941,000USD | 749,488,000USD | -124,599,000USD | 710,656,000USD | 336,227,000USD |
| Capital Expenditures | -58,867,000USD | -86,263,000USD | -47,486,000USD | -77,833,000USD | -181,006,000USD | -187,379,000USD | -78,064,000USD | -73,483,000USD |
| Free Cash Flow | 1,354,631,000USD | 249,074,000USD | 449,001,000USD | 892,108,000USD | 568,482,000USD | -311,978,000USD | 632,592,000USD | 262,744,000USD |
| Investments | -18,743,000USD | 157,517,000USD | -74,089,000USD | -709,000USD | -26,693,000USD | -81,622,000USD | -9,390,000USD | -12,940,000USD |
| Total Cashflows From Investing Activities | -102,610,000USD | 157,517,000USD | -207,677,000USD | -78,542,000USD | -207,699,000USD | -269,001,000USD | -87,454,000USD | -86,423,000USD |
| Net Borrowings | -4,544,000USD | -3,798,000USD | -3,360,000USD | -2,862,000USD | -2,417,000USD | -836,000USD | -822,000USD | -822,000USD |
| Total Cash From Financing Activities | 101,039,000USD | -2,021,547,000USD | -20,033,000USD | -794,000USD | 6,176,000USD | 71,709,000USD | 45,711,000USD | 14,657,000USD |
| Sale Purchase Of Stock | -19,100,000USD | -2,004,790,000USD | -28,550,000USD | -26,301,000USD | -29,940,000USD | -22,759,000USD | -16,751,000USD | 29,942,000USD |
| Change In Cash | 1,410,218,000USD | -1,525,770,000USD | 262,101,000USD | 893,960,000USD | 544,395,000USD | -318,942,000USD | 668,721,000USD | 264,552,000USD |
| Begin Period Cash Flow | 1,689,451,000USD | 3,215,221,000USD | 2,953,120,000USD | 2,059,160,000USD | 1,514,765,000USD | 1,833,707,000USD | 1,164,986,000USD | 900,434,000USD |
| End Period Cash Flow | 3,099,669,000USD | 1,689,451,000USD | 3,215,221,000USD | 2,953,120,000USD | 2,059,160,000USD | 1,514,765,000USD | 1,833,707,000USD | 1,164,986,000USD |
| Other Cashflows From Investing Activities | -25,000,000USD | -13,900,000USD | -47,486,000USD | -709,000USD | -181,006,000USD | -187,379,000USD | -78,064,000USD | -73,483,000USD |
| Other Cashflows From Financing Activities | -97,079,000USD | -62,260,000USD | -52,509,000USD | -59,047,000USD | -50,033,000USD | -37,760,000USD | -16,766,000USD | -15,285,000USD |
| Unclassified Operating Cash Flow | 247,685,000USD | -85,553,000USD | -158,898,000USD | 57,091,000USD | -465,604,000USD | — | — | — |
| Unclassified Financing Cash Flow | 221,762,000USD | 49,301,000USD | 64,386,000USD | 113,717,000USD | 118,506,000USD | 155,823,000USD | 96,801,000USD | — |
| Unclassified Investing Cash Flow | — | 100,163,000USD | -38,616,000USD | — | 181,006,000USD | 187,379,000USD | 78,064,000USD | 73,483,000USD |
| Change To Liabilities | — | — | — | 325,632,000USD | 204,782,000USD | 128,962,000USD | 58,862,000USD | 24,129,000USD |
| Dividends Paid | — | — | — | -26,301,000USD | -29,940,000USD | -22,759,000USD | -16,751,000USD | — |
| Cash And Cash Equivalents Changes | — | — | — | 890,605,000USD | 547,965,000USD | -321,891,000USD | 668,913,000USD | 264,461,000USD |
| Issuance Of Capital Stock | — | — | — | — | — | — | 0USD | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Geography | Europe | 105,131,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | Other Countries | 8,798,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | United States | 1,560,110,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Geography | Europe | 92,429,000 | USD | 0000879169-26-000026 |
| Q1 2026Quarterly · 2026-03-31 | Geography | Other Countries | 8,779,000 | USD | 0000879169-26-000026 |
| Q1 2026Quarterly · 2026-03-31 | Geography | United States | 1,171,468,000 | USD | 0000879169-26-000026 |
| Q4 2025Quarterly · 2025-12-31 | Geography | Europe | 75,990,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Geography | Other Countries | 6,075,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Geography | United States | 1,424,770,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Geography | Europe | 323,734,000 | USD | 0000879169-26-000010 |
| FY 2025Yearly · 2025-12-31 | Geography | Other Countries | 17,567,000 | USD | 0000879169-26-000010 |
| FY 2025Yearly · 2025-12-31 | Geography | United States | 4,799,941,000 | USD | 0000879169-26-000010 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Europe | 100,306,000 | USD | 0000879169-25-000118 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Other Countries | 4,413,000 | USD | 0000879169-25-000118 |
| Q3 2025Quarterly · 2025-09-30 | Geography | United States | 1,261,261,000 | USD | 0000879169-25-000118 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Europe | 78,826,000 | USD | 0000879169-25-000103 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Other Countries | 4,350,000 | USD | 0000879169-25-000103 |
| Q2 2025Quarterly · 2025-06-30 | Geography | United States | 1,132,353,000 | USD | 0000879169-25-000103 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Europe | 68,612,000 | USD | 0000879169-26-000026 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Other Countries | 2,729,000 | USD | 0000879169-26-000026 |
| Q1 2025Quarterly · 2025-03-31 | Geography | United States | 981,557,000 | USD | 0000879169-26-000026 |
| Q4 2024Quarterly · 2024-12-31 | Geography | Europe | 88,887,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | Other Countries | 2,502,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | United States | 1,087,298,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | Europe | 260,437,000 | USD | 0000879169-26-000010 |
| FY 2024Yearly · 2024-12-31 | Geography | Other Countries | 6,213,000 | USD | 0000879169-26-000010 |
| FY 2024Yearly · 2024-12-31 | Geography | United States | 3,974,567,000 | USD | 0000879169-26-000010 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Europe | 66,464,000 | USD | 0000879169-25-000118 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Other Countries | 1,367,000 | USD | 0000879169-25-000118 |
| Q3 2024Quarterly · 2024-09-30 | Geography | United States | 1,070,040,000 | USD | 0000879169-25-000118 |
| FY 2023Yearly · 2023-12-31 | Geography | Europe | 175,866,000 | USD | 0000879169-26-000010 |
| FY 2023Yearly · 2023-12-31 | Geography | Other Countries | 4,910,000 | USD | 0000879169-26-000010 |
| FY 2023Yearly · 2023-12-31 | Geography | United States | 3,514,873,000 | USD | 0000879169-26-000010 |
| Q1 2023Quarterly · 2023-03-31 | Product | ICLUSIG | 27,685,000 | USD | 0000879169-23-000016 |
| Q1 2023Quarterly · 2023-03-31 | Product | JAKAFI | 579,969,000 | USD | 0000879169-23-000016 |
| Q1 2023Quarterly · 2023-03-31 | Product | Jakavi Royalty Revenues | 76,692,000 | USD | 0000879169-23-000016 |
| Q1 2023Quarterly · 2023-03-31 | Product | Milestone And Contract Revenue | 0 | USD | 0000879169-23-000016 |
| Q1 2023Quarterly · 2023-03-31 | Product | Milestone Revenue | 0 | USD | 0000879169-23-000016 |
| Q1 2023Quarterly · 2023-03-31 | Product | MINJUVI | 6,556,000 | USD | 0000879169-23-000016 |
| Q1 2023Quarterly · 2023-03-31 | Product | Olumiant Royalty | 34,155,000 | USD | 0000879169-23-000016 |
| Q1 2023Quarterly · 2023-03-31 | Product | Opzelura | 56,552,000 | USD | 0000879169-23-000016 |
| Q1 2023Quarterly · 2023-03-31 | Product | Pemazyre | 22,475,000 | USD | 0000879169-23-000016 |
| Q1 2023Quarterly · 2023-03-31 | Product | Royalty — PEMAZYRERoyalty Revenues | 412,000 | USD | 0000879169-23-000016 |
| Q1 2023Quarterly · 2023-03-31 | Product | Tabrecta Royalty Revenues | 4,177,000 | USD | 0000879169-23-000016 |
| FY 2022Yearly · 2022-12-31 | Geography | Europe | 147,000,000 | USD | 0001628280-25-004633 |
| FY 2022Yearly · 2022-12-31 | Geography | Other | 47,635,000 | USD | 0001628280-25-004633 |
| FY 2022Yearly · 2022-12-31 | Geography | United States | 3,200,000,000 | USD | 0001628280-25-004633 |
| FY 2022Yearly · 2022-12-31 | Product | Milestone And Contract Revenue | 165,000,000 | USD | 0000879169-23-000008 |
| FY 2022Yearly · 2022-12-31 | Product | Product | 2,746,897,000 | USD | 0000879169-23-000008 |
| FY 2022Yearly · 2022-12-31 | Product | Royalty | 482,738,000 | USD | 0000879169-23-000008 |
| Q3 2022Quarterly · 2022-09-30 | Product | ICLUSIG | 25,929,000 | USD | 0000879169-22-000010 |
| Q3 2022Quarterly · 2022-09-30 | Product | JAKAFI | 619,595,000 | USD | 0000879169-22-000010 |
| Q3 2022Quarterly · 2022-09-30 | Product | Jakavi Royalty Revenues | 85,808,000 | USD | 0000879169-22-000010 |
| Q3 2022Quarterly · 2022-09-30 | Product | Milestone And Contract Revenue | 0 | USD | 0000879169-22-000010 |
| Q3 2022Quarterly · 2022-09-30 | Product | Milestone Revenue | 0 | USD | 0000879169-22-000010 |
| Q3 2022Quarterly · 2022-09-30 | Product | MINJUVI | 5,932,000 | USD | 0000879169-22-000010 |
| Q3 2022Quarterly · 2022-09-30 | Product | Olumiant | 0 | USD | 0000879169-22-000010 |
| Q3 2022Quarterly · 2022-09-30 | Product | Olumiant Royalty | 20,371,000 | USD | 0000879169-22-000010 |
| Q3 2022Quarterly · 2022-09-30 | Product | Opzelura | 38,140,000 | USD | 0000879169-22-000010 |
| Q3 2022Quarterly · 2022-09-30 | Product | Pemazyre | 23,414,000 | USD | 0000879169-22-000010 |
| Q3 2022Quarterly · 2022-09-30 | Product | Tabrecta Royalty Revenues | 4,114,000 | USD | 0000879169-22-000010 |
| Q2 2022Quarterly · 2022-06-30 | Product | Milestone Revenue | 130,000,000 | USD | 0001558370-22-011631 |
| Q2 2022Quarterly · 2022-06-30 | Product | Product | 663,851,000 | USD | 0001558370-22-011631 |
| Q2 2022Quarterly · 2022-06-30 | Product | Royalty | 117,546,000 | USD | 0001558370-22-011631 |
| Q1 2022Quarterly · 2022-03-31 | Product | ICLUSIG | 26,069,000 | USD | 0000879169-23-000016 |
| Q1 2022Quarterly · 2022-03-31 | Product | JAKAFI | 544,464,000 | USD | 0000879169-23-000016 |
| Q1 2022Quarterly · 2022-03-31 | Product | Jakavi Royalty Revenues | 70,867,000 | USD | 0000879169-23-000016 |
| Q1 2022Quarterly · 2022-03-31 | Product | MINJUVI | 4,502,000 | USD | 0000879169-23-000016 |
| Q1 2022Quarterly · 2022-03-31 | Product | Olumiant Royalty | 48,064,000 | USD | 0000879169-23-000016 |
| Q1 2022Quarterly · 2022-03-31 | Product | Opzelura | 12,754,000 | USD | 0000879169-23-000016 |
| Q1 2022Quarterly · 2022-03-31 | Product | Other | 5,000,000 | USD | 0000879169-23-000016 |
| Q1 2022Quarterly · 2022-03-31 | Product | Pemazyre | 18,032,000 | USD | 0000879169-23-000016 |
| Q1 2022Quarterly · 2022-03-31 | Product | PEMAZYRERoyalty Revenues | 0 | USD | 0000879169-23-000016 |
| Q1 2022Quarterly · 2022-03-31 | Product | Tabrecta Royalty Revenues | 3,483,000 | USD | 0000879169-23-000016 |
| FY 2021Yearly · 2021-12-31 | Product | Milestone And Contract Revenue | 95,000,000 | USD | 0000879169-23-000008 |
| FY 2021Yearly · 2021-12-31 | Product | Product | 2,322,012,000 | USD | 0000879169-23-000008 |
| FY 2021Yearly · 2021-12-31 | Product | Royalty | 569,255,000 | USD | 0000879169-23-000008 |
| Q3 2021Quarterly · 2021-09-30 | Product | ICLUSIG | 28,522,000 | USD | 0000879169-22-000010 |
| Q3 2021Quarterly · 2021-09-30 | Product | JAKAFI | 547,373,000 | USD | 0000879169-22-000010 |
| Q3 2021Quarterly · 2021-09-30 | Product | Jakavi Royalty Revenues | 94,655,000 | USD | 0000879169-22-000010 |
| Q3 2021Quarterly · 2021-09-30 | Product | MINJUVI | 556,000 | USD | 0000879169-22-000010 |
| Q3 2021Quarterly · 2021-09-30 | Product | Olumiant Royalty | 86,572,000 | USD | 0000879169-22-000010 |
| Q3 2021Quarterly · 2021-09-30 | Product | Opzelura | 0 | USD | 0000879169-22-000010 |
| Q3 2021Quarterly · 2021-09-30 | Product | Other | 35,000,000 | USD | 0000879169-22-000010 |
| Q3 2021Quarterly · 2021-09-30 | Product | Pemazyre | 17,562,000 | USD | 0000879169-22-000010 |
| Q3 2021Quarterly · 2021-09-30 | Product | Tabrecta Royalty Revenues | 2,747,000 | USD | 0000879169-22-000010 |
| Q2 2021Quarterly · 2021-06-30 | Product | Milestone Revenue | 10,000,000 | USD | 0001558370-22-011631 |
| Q2 2021Quarterly · 2021-06-30 | Product | Product | 575,150,000 | USD | 0001558370-22-011631 |
| Q2 2021Quarterly · 2021-06-30 | Product | Royalty | 120,559,000 | USD | 0001558370-22-011631 |
| Q1 2021Quarterly · 2021-03-31 | Product | ICLUSIG | 25,645,000 | USD | 0001558370-22-006808 |
| Q1 2021Quarterly · 2021-03-31 | Product | JAKAFI | 465,710,000 | USD | 0001558370-22-006808 |
| Q1 2021Quarterly · 2021-03-31 | Product | Jakavi Royalty Revenues | 65,602,000 | USD | 0001558370-22-006808 |
| Q1 2021Quarterly · 2021-03-31 | Product | Olumiant Royalty | 32,258,000 | USD | 0001558370-22-006808 |
| Q1 2021Quarterly · 2021-03-31 | Product | Pemazyre | 13,456,000 | USD | 0001558370-22-006808 |
| Q1 2021Quarterly · 2021-03-31 | Product | Tabrecta | 2,000,000 | USD | 0001558370-22-006808 |
| Q1 2021Quarterly · 2021-03-31 | Product | Tabrecta Royalty Revenues | 2,047,000 | USD | 0001558370-22-006808 |
| Q4 2020Quarterly · 2020-12-31 | Product | Milestone And Contract Revenue | 110,000,000 | USD | 0001558370-21-000825 |
| Q4 2020Quarterly · 2020-12-31 | Product | Product | 559,500,000 | USD | 0001558370-21-000825 |
| Q4 2020Quarterly · 2020-12-31 | Product | Royalty | 119,900,000 | USD | 0001558370-21-000825 |
| FY 2020Yearly · 2020-12-31 | Product | Milestone And Contract Revenue | 205,000,000 | USD | 0000879169-23-000008 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.